News Release

<< Back
Printer Friendly Version View printer-friendly version
Zix Corporation Chosen by Focus Diagnostics for Laboratory Connectivity Services

National Pharmaceutical and Healthcare Laboratory Signs Three-Year Contract for Dr. Chart(R)

DALLAS, Jan 18, 2005 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (Nasdaq:ZIXI), a global provider of secure e-messaging, e-prescribing, and e-transaction applications and services, today announced that Focus Diagnostics, Inc. has signed a three-year contract for ZixCorp's Dr. Chart online order entry and results reporting services. Focus Diagnostics will market the product as FocusLink(R), a part of its connectivity suite of products, and expects to dramatically increase the number of deployments in its client locations by the end of the year.

Dr. Chart is a Web-based connectivity tool that links laboratories efficiently and securely to the healthcare providers they serve. The service enables healthcare providers to initiate lab orders, check medical necessity compliance, and view results rapidly and accurately.

"Dr Chart best fits our current client base and positions us for future connectivity growth," said Rodny Mitsuuchi, director of information technology for Focus Diagnostics. "It provides ease of use, flexibility, and access to our catalog of over 1,200 tests. We're excited that we can provide these valuable benefits to our laboratory clients."

"Focus has continued to be on the cutting edge of new and innovative services that help laboratories work more efficiently and we're proud that it has selected Dr. Chart not only to improve its connectivity with clients but also to become a reference account for us," said Eric Reynolds, director of Dr. Chart sales and business development for ZixCorp. "Dr. Chart's simple ordering process and the power of the ZixData Center(TM) create an easy-to-use service with superior reliability that benefits both laboratories and healthcare providers."

About Focus Diagnostics

Focus Diagnostics is a healthcare and life sciences company based in Herndon, Va. The Healthcare Diagnostics Group, based in Cypress, Calif., specializes in the areas of infectious and autoimmune diseases and provides a broad array of innovative services and products to commercial laboratories, hospitals, and public health facilities worldwide. The Pharmaceutical Diagnostics Group, marketed as Focus Bio-Inova, is a provider of global central laboratory and custom microbiology testing services. For more information, visit

About Zix Corporation

Zix Corporation (ZixCorp(R)) provides easy-to-use-and-deploy e-communication services that protect, manage, and deliver sensitive information to enterprises and consumers in healthcare, finance, insurance and government. ZixCorp's secure e-messaging services enable policy-driven email encryption, content filtering and send-to-anyone capability while its e-prescribing and e-lab services improve patient care, reduce costs, and improve efficiency. For more information, visit

SOURCE: Zix Corporation

Public Relations
Christa Osswald, 214-370-2175
Investor Relations
Peter Wilensky, 214-515-7357